HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Rose Sheet

Executive Summary

Aquafresh 9% sales increase helps offset poor performances in SmithKline Beecham's other oral care brands in the third quarter, the company says Oct. 31. Worldwide oral care sales were up 2% to $244 mil. for the quarter and OTC drug sales remained unchanged at $489 mil., due in part to generic competition in smoking cessation products, SB reports on same-day conference call. Consolidated sales rose 6% to $3.25 bil. and income was up 21% to $589 mil., excluding a $57 mil. charge related to SB's restructuring program from proposed Glaxo Wellcome merger



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts